Stephen Chang

Stephen Chang is a seasoned biotechnology executive with extensive experience in leadership roles within various organizations. Currently serving as a board member at Mirimus since January 2021, Stephen's previous positions include board member and scientific advisory board member at Histogen from January 2008 to March 2021 and chair of the board of directors in the office of the CEO. Stephen has held senior leadership roles, such as senior vice president of research and development at The New York Stem Cell Foundation, chief scientific officer at Stemgent Inc., and executive director at CURES. Additionally, Stephen has been involved with BIOCOM's board of directors and served as CEO and president of Multicell Technologies. Stephen's educational background includes a PhD in Biochemical Genetics from UC Irvine and a bachelor's degree from the University of Michigan.